This site is intended for healthcare professionals only
LoginRegister
Corbevax gets DCGI emergency use nod for 12-18 age groupCorbevax gets DCGI emergency use nod for 12-18 age group
South Korean company to develop combined vaccine for COVID, influenzaSouth Korean company to develop combined vaccine for COVID, influenza
Panacea Biotec, CEPI, THSTI partner to develop broadly protective Betacoronavirus vaccinesPanacea Biotec, CEPI, THSTI partner to develop broadly protective Betacoronavirus vaccines
Biological E Corbevax gets DCGI nod for 12-18 yearsBiological E Corbevax gets DCGI nod for 12-18 years
US FDA considers approving a second Covid-19 booster shot: ReportUS FDA considers approving a second Covid-19 booster shot: Report
GSK application to expand use of Nucala for COPD accepted for review by EMAGSK halts respiratory virus vaccine trial in pregnant women
Moderna to develop mRNA-based vaccine for shinglesModerna to develop mRNA-based vaccine for shingles
Novavax COVID vaccine gets nod in CanadaNovavax COVID vaccine gets nod in Canada
BioNTech- Pfizer Omicron vaccine delayed, says BioNTech Chief Ugur SahinBioNTech- Pfizer Omicron vaccine delayed, says BioNTech Chief Ugur Sahin
Omicron-specific booster could be ready by August: Moderna CEOOmicron-specific booster could be ready by August: Moderna CEO
Study says three doses of Pfizer COVID vaccine better than twoStudy says three doses of Pfizer COVID vaccine better than two
Biological E Corbevax safe, offers high antibody levels: NTAGI ChairmanBiological E Corbevax safe, offers high antibody levels: NTAGI Chairman
X